COVID-19 and Indian pharma industry

Authors : G Vidyasagar

DOI : 10.18231/j.ijpp.2021.017

Volume : 8

Issue : 2

Year : 2021

Page No : 100-101


Citation Data


Related Articles

Clinico-microbiological perspective of corneal ulcer

Chandrakanth Reddy, Kausika Garapati

Correlation of serum D-dimer levels with stages of diabetic retinopathy and gycosylated hemoglobin levels

Kiran Shetty, Lakshmi K*, Sarita Lobo, Vivekanad U

Estimation of mercury levels in blood by GFAAS after administration of two variants of Shwasakuthara Rasa in human volunteers

Trupti Patil-Bhole, Seeba Varghese, Ravindra Sonavane, Bharat Kale

Insights into molecular docking: A comprehensive view

Krishna R. Gupta, Yogeshri J. Jibhkate, Atul T. Hemke, Milind J Umekar, Sushil S. Burle

Therapeutic drug monitoring: The future of tuberculosis management

Gyanshankar Mishra

Review Gluteus Medius Muscle Function Al Limitation in Chronic Low Back Pain

Muheebur Rehman, Khalid Aslam, Suad Islam, Huma Zia, Kashif Ullah, Faiz ur Rehman

Clinical profile of patients with interstitial lung disease in connective tissue disorders – An original study

Abhishek Nuchin, Girija Nair, Balaji Tuppekar, Shahid Patel, Abhay Uppe

Let’s understand the position of academic libraries in views of different users

S. L. Jadhav

Disability, quality of life enjoyment and satisfaction of patients with bipolar affective disorder in remission

Srikanth Lella, Therissa Benerji*, Madhavi Kodali, Roshan Miyan, Krishna Mohan Parvathaneni